Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Anne I. Kraemer, Chloé Chong, Florian Huber, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 608-628
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

The 2024 Report on the Human Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Sandra Orchard, Lydie Lane, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 12, pp. 5296-5311
Closed Access | Times Cited: 2
Immunopeptidomics in the Era of Single-Cell Proteomics
Rupert L. Mayer, Karl Mechtler
Biology (2023) Vol. 12, Iss. 12, pp. 1514-1514
Open Access | Times Cited: 6
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing
Paul Shafer, Wingchi K. Leung, Mae Woods, et al.
Cytotherapy (2024) Vol. 26, Iss. 3, pp. 266-275
Open Access | Times Cited: 1
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
Sylvie Rusakiewicz, Svitlana Tyekucheva, S. Tissot-Renaud, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113535-113535
Closed Access | Times Cited: 1
Immunogenicity of Non-mutated Ovarian Cancer-Specific Antigens
Leslie Hesnard, Catherine Thériault, M Cahuzac, et al.
(2024)
Open Access | Times Cited: 1
Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens
Leslie Hesnard, Catherine Thériault, M Cahuzac, et al.
Current Oncology (2024) Vol. 31, Iss. 6, pp. 3099-3121
Open Access | Times Cited: 1
Gene and protein sequence features augment HLA class I ligand predictions
Kaspar Bresser, Benoît P. Nicolet, Anita Jekő, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114325-114325
Open Access | Times Cited: 1
Immunopeptidomics in the cancer immunotherapy era
Sutatip Pongcharoen, Nongphanga Kaewsringam, Poorichaya Somaparn, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 801-817
Open Access | Times Cited: 1
In situ endoscopic photodynamic therapy combined with immature DC vaccination induces a robust T cell response against peritoneal carcinomatosis
Charline Degavre, Anouk Lepez, Sébastien Ibanez, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009752-e009752
Open Access | Times Cited: 1
A post-translational cysteine-to-serine conversion in human and mouse insulin generates a diabetogenic neoepitope
Neetu Srivastava, Anthony N. Vomund, Orion J. Peterson, et al.
(2024)
Closed Access | Times Cited: 1
Sepsis and acute respiratory failure in patients with cancer: how can we improve care and outcomes even further?
Patrick G. Lyons, Colleen McEvoy, Brandon Hayes‐Lattin
Current Opinion in Critical Care (2023) Vol. 29, Iss. 5, pp. 472-483
Closed Access | Times Cited: 2
A complete mass spectrometry-based immunopeptidomics pipeline for neoantigen identification and validation
Ming Li, Ngoc Hieu Tran, Chao Peng, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
Keisuke Shigeta, Kazuhiro Matsumoto, Sotaro Kitaoka, et al.
European Urology Oncology (2024)
Open Access
Distinct evolutionary patterns of tumor immune escape and elimination determined by ECM architectures
Yijia Fan, Jason T. George
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Causal role of immune cells in lung cancer subtypes: Mendelian randomization study
Jiaxin Li, Tiantian Xuan, Zhanmei Wang, et al.
Human Immunology (2024) Vol. 85, Iss. 5, pp. 111087-111087
Closed Access
Exploring the causal relationship between the immune cell-inflammatory factor axis and lung cancer: a Mendelian randomization study
Lin Zhu, Zhi Jin
Frontiers in Oncology (2024) Vol. 14
Open Access
Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation
Pablo Juanes‐Velasco, Carlota Arias‐Hidalgo, Marina L. García‐Vaquero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9564-9564
Open Access
Spatial transcriptome analysis of lung squamous cell carcinoma arising from interstitial pneumonia provides insights into tumor heterogeneity
Koto Ukon, Satoshi Nojima, Daisuke Motooka, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155805-155805
Open Access
RNA splicing junction landscape reveals abundant tumor-specific transcripts in human cancer
Qin Li, Ziteng Li, Bing Chen, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114893-114893
Open Access
Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines
Kevin A. Kovalchik, David Hamelin, Peter Kubiniok, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Discovering and Validating Neoantigens by Mass Spectrometry-based Immunopeptidomics and Deep Learning
Ngoc Hieu Tran, Chao Peng, Qingyang Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Taking the temperature of lung cancer antigens
Paul A. Stewart, Alex M. Jaeger
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 586-587
Closed Access
Recent advances in immunopeptidomic-based tumor neoantigen discovery
Wei Meng, Robert D. Schreiber, Cheryl F. Lichti
Advances in immunology (2023), pp. 1-36
Closed Access
Previous Page - Page 2

Scroll to top